US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

eXoZymes Inc

11.00

+0.24502.28%

Volume:5.55K

Turnover:60.94K

Market Cap:92.05M

PE:-12.32

High:11.30

Open:11.30

Low:10.75

Close:10.76

Loading ...

Overview Company News Filings

Bringing clarity and precision to the cell-free space by introducing exozymes

BioClick – an enzyme engineering game-changer, launched by eXoZymes and supported by a $300K NIH grant

eXoZymes appoints experienced biomanufacturing executive, Damien Perriman, as CCO

eXoZymes Provides Fourth Quarter and Full Year 2024 Update

MDB Capital Holdings Provides Fourth Quarter and Full Year 2024 Update

eXoZymes Inc trading halted, volatility trading pause

New to the Street Airs Show #630 on Fox Business Network Tonight at 10:30 PM PST Featuring Roadzen ($RDZN), BioVie ($BIVI), AtlasClear (ATCH), eXoZymes ($EXOZ), and EvolveHealthandLifestyle.com With Craig Bruce

ACCESS Newswire

Leadership Transition Announced at eXoZymes, MDB CEO Marlett Named Chairman

eXoZymes president, chairman Hayat transitions out of roles

Exozymes Inc: Christopher Marlett Will Assume Role of Chairman

THOMSON REUTERS

Exozymes Inc: Mo Hayat Transitioned Out of His Roles as Chairman of Board and President

THOMSON REUTERS

eXoZymes and MDB Capital Announce Leadership Transition at eXoZymes Inc.

eXoZymes Inc trading resumes

eXoZymes Inc trading halted, volatility trading pause

Exozymes Announces Nasdaq Bell Ringing to Commemorate Initial Public Offering

THOMSON REUTERS

Institutional investors own a significant stake of 42% in Invizyne Technologies, Inc. (NASDAQ:IZTC)

Simply Wall St.

Rebranding Invizyne to eXoZymes Signifies a Sustainable Paradigm Shift in Chemical Production Leveraging AI-Engineered Enzymes

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/EXOZ/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"EXOZ","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"EXOZ\",,,,,undefined,":{"symbol":"EXOZ","market":"US","secType":"STK","nameCN":"eXoZymes Inc","latestPrice":11,"timestamp":1746648000000,"preClose":10.755,"halted":0,"volume":5554,"delay":0,"floatShares":6271276,"shares":8367810,"eps":-0.893053,"marketStatus":"Post-Mkt","change":0.245,"latestTime":"05-07 16:53:38 EDT","open":11.3,"high":11.3,"low":10.75,"amount":60942.2505,"amplitude":0.051139,"askPrice":13.56,"askSize":100,"bidPrice":10.99,"bidSize":309,"shortable":3,"etf":0,"ttmEps":-0.893053,"tradingStatus":3,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1746662400000},"marketStatusCode":4,"adr":0,"listingDate":1731474000000,"exchange":"NASDAQ","adjPreClose":10.755,"preHourTrading":{"tag":"盘前","latestPrice":11.32,"preClose":10.79,"latestTime":"08:00 EDT","volume":20,"amount":226.4,"timestamp":1746619201090},"volumeRatio":1.877112},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"EXOZ\",,,,,undefined,":{"symbol":"EXOZ","floatShares":6271276,"roa":"-44.69%","roe":"-116.80%","lyrEps":-0.893053,"volumeRatio":1.877112,"shares":8367810,"dividePrice":0,"high":11.3,"amplitude":0.051139,"preClose":10.755,"low":10.75,"week52Low":8.5,"pbRate":"8.83","psRate":"-131494.16","week52High":23.99,"institutionHeld":0,"latestPrice":11,"committee":0.511002,"eps":-0.893053,"divideRate":0,"volume":5554,"delay":0,"ttmEps":-0.893053,"open":11.3,"prevYearClose":16.5,"prevWeekClose":10.89,"prevMonthClose":11,"prevQuarterClose":10.45,"fiveDayClose":11,"twentyDayClose":10.02,"sixtyDayClose":15.5},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"EXOZ\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2529330246","title":"Bringing clarity and precision to the cell-free space by introducing exozymes","url":"https://stock-news.laohu8.com/highlight/detail?id=2529330246","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529330246?lang=en_us&edition=fundamental","pubTime":"2025-04-22 04:10","pubTimestamp":1745266200,"startTime":"0","endTime":"0","summary":"Dr. Tyler Korman, co-founder and VP of Research at eXoZymes, is excited about the 'exozymes' cover story in GEN Biotechnology, which is freely available as an Open Access paper. Scientific definition of exozymes featured as cover story in GEN Biotechnology, freely available as an Open Access paper. The author team introduces the terms ‘exozymes’ to bring clarity to the rapidly evolving field of cell-free biomanufacturing—a biomanufacturing method to produce chemicals without relying on living cells like bacteria or yeast. The paper features co-authors from multiple institutions such as The National Renewable Laboratory , UCLA, Caltech, University of Colorado Boulder, Sepia Biosciences, as well as the venture studio, Ferment. The authors intend the terms to be freely available for use by the broader scientic community, and no trademarks have been led. Dr. Kevin Davies, Executive Editor of GEN Biotechnology, adds, \"The team at eXoZymes caught our eye recently with its very well-orchestra","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/bringing-clarity-precision-cell-free-201000670.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4097","EXOZ","BK4139","BK4585","GEN","BK4588","LU2286300806.USD"],"gpt_icon":0},{"id":"2526115541","title":"BioClick – an enzyme engineering game-changer, launched by eXoZymes and supported by a $300K NIH grant","url":"https://stock-news.laohu8.com/highlight/detail?id=2526115541","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2526115541?lang=en_us&edition=fundamental","pubTime":"2025-04-11 04:30","pubTimestamp":1744317000,"startTime":"0","endTime":"0","summary":"Monrovia, CA, April  10, 2025  (GLOBE NEWSWIRE) -- Today, eXoZymes Inc. (NASDAQ: EXOZ) (“eXoZymes”) - a pioneer of AI-engineered enzymes that can transform sustainable feedstock into nutraceuticals, m","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/04/10/3059738/0/en/BioClick-an-enzyme-engineering-game-changer-launched-by-eXoZymes-and-supported-by-a-300K-NIH-grant.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["EXOZ","BK4139"],"gpt_icon":0},{"id":"2524445026","title":"eXoZymes appoints experienced biomanufacturing executive, Damien Perriman, as CCO","url":"https://stock-news.laohu8.com/highlight/detail?id=2524445026","media":"GlobeNewswire","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524445026?lang=en_us&edition=fundamental","pubTime":"2025-04-03 04:10","pubTimestamp":1743624600,"startTime":"0","endTime":"0","summary":"Expanded leadership team as eXoZymes ramps up commercial growth. Damien Perriman brings more than two decades of experience in successfully developing and commercializing novel biotechnologies. Focus on developing commercial opportunities, spin-outs, joint-ventures, and licensing deals with future partners. Monrovia, CA, April 02, 2025  -- Today, eXoZymes Inc.   - a pioneer of AI-engineered enzymes that can transform sustainable feedstock into essential chemicals, medicines, and biofuels - announced the appointment of Damien Perriman to a newly created role as Chief Commercial Officer .Perriman brings more than two decades of experience in successfully commercializing several biotechnologies, spanning diverse markets such as nutrition, personal care, plastics, textiles, fragrances, performance fuels, and specialty chemicals. Before joining eXoZymes, Perriman most recently has served leading commercial roles at both Genomatica  and Gevo, while also serving as Chairman of the Board of Da","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/exozymes-appoints-experienced-biomanufacturing-executive-201000244.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU0823414551.USD","CCO","LU0823414478.USD","BK4009","EXOZ","LU2506951792.HKD","BK4139","LU2249611893.SGD","LU2294711713.HKD","LU2357125470.USD"],"gpt_icon":0},{"id":"2524078445","title":"eXoZymes Provides Fourth Quarter and Full Year 2024 Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2524078445","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524078445?lang=en_us&edition=fundamental","pubTime":"2025-04-03 04:05","pubTimestamp":1743624300,"startTime":"0","endTime":"0","summary":"Management to Host Conference Call Today at 4:30PM Eastern. Monrovia, CA, April 02, 2025  -- Today, eXoZymes Inc.   - a pioneer of AI-engineered enzymes that can transform sustainable feedstock into essential nutraceuticals, medicines, biofuels, and other valuable chemicals - provides an update on operations through the fiscal year ended December 31, 2024.Michael Heltzen, CEO of eXoZymes, states, “As a pre-revenue company, what’s important for us is that we keep progressing towards our specific milestones and value infection points, like getting to our first commercial applications via spin-outs, joint-ventures, and licensing deals as the drivers of our focus on commercialization. All while making sure to keep improving our fundamental and innovative exozymes technology, as well as growing our team of talents.”Fourth Quarter and Full Year 2024 and Subsequent Operational Highlights. Completed initial public offering: While 2024 was a challenging year to raise money for bio- and high-tec","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/exozymes-provides-fourth-quarter-full-200500995.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["EXOZ","BK4139"],"gpt_icon":0},{"id":"2524284974","title":"MDB Capital Holdings Provides Fourth Quarter and Full Year 2024 Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2524284974","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524284974?lang=en_us&edition=fundamental","pubTime":"2025-04-01 04:05","pubTimestamp":1743451500,"startTime":"0","endTime":"0","summary":"Management to Host Conference Call Today at 4:30 p.m. ETAddison, TX, March  31, 2025  (GLOBE NEWSWIRE) -- MDB Capital Holdings, LLC, (NASDAQ: MDBH) (“MDB”), a public venture platform focused on launch","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/03/31/3052772/0/en/MDB-Capital-Holdings-Provides-Fourth-Quarter-and-Full-Year-2024-Update.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4116","LU0719512351.SGD","BK4139","LU2272731600.USD","LU1951200564.SGD","IP","LU1923623000.USD","LU2272731782.SGD","BK4588","LU2087625088.SGD","MDBH","LU1720051017.SGD","LU0353189763.USD","LU1992135399.USD","LU1861220033.SGD","EXOZ","LU1487256676.USD","MDB","LU0353189680.USD","LU1481600234.SGD","BK4585","LU1951198990.SGD","LU1720051108.HKD","BK4136","LU2463526074.USD","LU1861215975.USD","LU1992135472.HKD","IE00B3T34201.USD","BK4127","LU0823434740.USD","LU0823434583.USD","BK4607","LU1481599808.USD","LU1548497426.USD","LU0390134368.USD","BK4608","BK4613","LU2357305700.SGD","LU0082616367.USD"],"gpt_icon":0},{"id":"2520307505","title":"eXoZymes Inc trading halted, volatility trading pause","url":"https://stock-news.laohu8.com/highlight/detail?id=2520307505","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520307505?lang=en_us&edition=fundamental","pubTime":"2025-03-18 01:35","pubTimestamp":1742232935,"startTime":"0","endTime":"0","summary":"13:33 EDT eXoZymes (EXOZ) Inc trading halted, volatility trading pause Published first on TheFly – the ultimate source for real-time, market-moving...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/exozymes-inc-trading-halted-volatility-trading-pause-2?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/exozymes-inc-trading-halted-volatility-trading-pause-2?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["EXOZ","BK4139"],"gpt_icon":0},{"id":"2516694249","title":"New to the Street Airs Show #630 on Fox Business Network Tonight at 10:30 PM PST Featuring Roadzen ($RDZN), BioVie ($BIVI), AtlasClear (ATCH), eXoZymes ($EXOZ), and EvolveHealthandLifestyle.com With Craig Bruce","url":"https://stock-news.laohu8.com/highlight/detail?id=2516694249","media":"ACCESS Newswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516694249?lang=en_us&edition=fundamental","pubTime":"2025-03-04 09:40","pubTimestamp":1741052400,"startTime":"0","endTime":"0","summary":"Also Featuring The Sustainable Green Team  with Shark Tank’s Kevin Harrington Showcasing Their WaterLess Garden Product. Additionally, the episode will spotlight The Sustainable Green Team  with Shark Tank's Kevin Harrington, discussing the company's groundbreaking WaterLess Garden product-an eco-friendly solution tackling water conservation challenges in agriculture and landscaping.\"We are excited to be going on our 17th year and will hit our 700th show this year,\" said Vince Caruso, Co-Founder and CEO of New to The Street. \"Additionally, we are adding T.V. commercial support across the board for our brand and clients to educate the public weekly.\". With a multi-platform strategy that combines broadcast television, earned media, social engagement, and strategic outdoor placements, New to The Street continues to expand its reach, providing companies with unparalleled exposure across major media channels.Never miss an interview-an \"Opportunity To Consider\" again!A clinical-stage biophar","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/street-airs-show-630-fox-014000774.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BIVI","ATCH","QLD","USAW.SI","PST","MNQmain","EXOZ","BK4127","RDZNW","TQQQ","RDZN","BK4139","TSYW.SI","NQmain","USJW.SI","QID","PSQ","SQQQ",".IXIC","BK4023","NVIW.SI"],"gpt_icon":1},{"id":"2513691248","title":"Leadership Transition Announced at eXoZymes, MDB CEO Marlett Named Chairman","url":"https://stock-news.laohu8.com/highlight/detail?id=2513691248","media":"Dow Jones","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2513691248?lang=en_us&edition=fundamental","pubTime":"2025-02-22 05:47","pubTimestamp":1740174420,"startTime":"0","endTime":"0","summary":"EXoZymes and MDB Capital Holdings said Mo Hayat has transitioned out of his roles as chairman and president. Christopher Marlett, MDB's chief executive, will become chairman.Marlett will ensure MDB will continue to provide help and support for eXoZymes, the company said Friday. Hayat will focus on new MDB Capital ventures.Edgardo Rayo will also join the board on behalf of MDB Capital, according to eXoZymes.The transition follows eXoZymes' corporate rebranding from Invizyne Technologies, which took place earlier this month. Shares trade on the Nasdaq under the symbol EXOZ.","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0082616367.USD","LU1548497426.USD","LU2087625088.SGD","LU1720051108.HKD","BK4116","BK4585","LU1861220033.SGD","LU1992135472.HKD","BK4607","LU0390134368.USD","BK4588","LU0823434583.USD","BK4127","LU1720051017.SGD","LU1861215975.USD","LU0353189763.USD","BK4139","MDB","LU0719512351.SGD","LU2272731600.USD","MDBH","LU2357305700.SGD","LU0823434740.USD","LU2272731782.SGD","LU0353189680.USD","LU1992135399.USD","BK4608","EXOZ"],"gpt_icon":0},{"id":"2513061217","title":"eXoZymes president, chairman Hayat transitions out of roles","url":"https://stock-news.laohu8.com/highlight/detail?id=2513061217","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2513061217?lang=en_us&edition=fundamental","pubTime":"2025-02-22 05:10","pubTimestamp":1740172227,"startTime":"0","endTime":"0","summary":"eXoZymes Inc. (EXOZ) and MDB Capital Holdings (MDBH) announced key leadership changes within the eXoZymes board of directors. Mo Hayat has transiti...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/exozymes-president-chairman-hayat-transitions-out-of-roles?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/exozymes-president-chairman-hayat-transitions-out-of-roles?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["MDBH","BK4127","EXOZ","BK4139"],"gpt_icon":0},{"id":"2513217994","title":"Exozymes Inc:  Christopher Marlett Will Assume Role of Chairman","url":"https://stock-news.laohu8.com/highlight/detail?id=2513217994","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2513217994?lang=en_us&edition=fundamental","pubTime":"2025-02-22 05:06","pubTimestamp":1740171970,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250221:nFWN3PC26C:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4127","EXOZ","BK4139","MDBH"],"gpt_icon":0},{"id":"2513217991","title":"Exozymes Inc:  Mo Hayat Transitioned Out of His Roles as Chairman of Board and President","url":"https://stock-news.laohu8.com/highlight/detail?id=2513217991","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2513217991?lang=en_us&edition=fundamental","pubTime":"2025-02-22 05:06","pubTimestamp":1740171970,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250221:nFWN3PC26C:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","BK4127","MDBH","EXOZ"],"gpt_icon":0},{"id":"2513217759","title":"eXoZymes and MDB Capital Announce Leadership Transition at eXoZymes Inc.","url":"https://stock-news.laohu8.com/highlight/detail?id=2513217759","media":"GlobeNewswire","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2513217759?lang=en_us&edition=fundamental","pubTime":"2025-02-22 05:05","pubTimestamp":1740171900,"startTime":"0","endTime":"0","summary":"Monrovia, CA, Feb.  21, 2025  (GLOBE NEWSWIRE) -- eXoZymes Inc. (NASDAQ: EXOZ, formerly Invizyne Technologies) - a pioneer of AI-engineered enzymes that can transform sustainable feedstock into essent","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/02/21/3030697/0/en/eXoZymes-and-MDB-Capital-Announce-Leadership-Transition-at-eXoZymes-Inc.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2272731600.USD","LU1548497426.USD","LU0823434583.USD","LU2087625088.SGD","BK4127","LU0719512351.SGD","LU1861220033.SGD","LU2272731782.SGD","LU1720051108.HKD","LU1992135472.HKD","LU2357305700.SGD","LU0353189680.USD","BK4588","MDB","LU1861215975.USD","LU0082616367.USD","BK4585","LU0390134368.USD","BK4139","LU0353189763.USD","BK4116","LU1992135399.USD","BK4607","BK4608","EXOZ","MDBH","LU1720051017.SGD","LU0823434740.USD"],"gpt_icon":0},{"id":"2512483041","title":"eXoZymes Inc trading resumes","url":"https://stock-news.laohu8.com/highlight/detail?id=2512483041","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2512483041?lang=en_us&edition=fundamental","pubTime":"2025-02-19 22:40","pubTimestamp":1739976031,"startTime":"0","endTime":"0","summary":"09:35 EST eXoZymes (EXOZ) Inc trading resumes Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news....","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/exozymes-inc-trading-resumes?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/exozymes-inc-trading-resumes?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","EXOZ"],"gpt_icon":0},{"id":"2512948894","title":"eXoZymes Inc trading halted, volatility trading pause","url":"https://stock-news.laohu8.com/highlight/detail?id=2512948894","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2512948894?lang=en_us&edition=fundamental","pubTime":"2025-02-19 22:35","pubTimestamp":1739975746,"startTime":"0","endTime":"0","summary":"09:30 EST eXoZymes (EXOZ) Inc trading halted, volatility trading pause Published first on TheFly – the ultimate source for real-time, market-moving...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/exozymes-inc-trading-halted-volatility-trading-pause?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/exozymes-inc-trading-halted-volatility-trading-pause?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["EXOZ","BK4139"],"gpt_icon":0},{"id":"2512010404","title":"Exozymes Announces Nasdaq Bell Ringing to Commemorate Initial Public Offering","url":"https://stock-news.laohu8.com/highlight/detail?id=2512010404","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2512010404?lang=en_us&edition=fundamental","pubTime":"2025-02-19 21:25","pubTimestamp":1739971500,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250219:nTUA4JSKNX:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","BK4127","EXOZ","MDBH"],"gpt_icon":0},{"id":"2511426395","title":"Institutional investors own a significant stake of 42% in Invizyne Technologies, Inc. (NASDAQ:IZTC)","url":"https://stock-news.laohu8.com/highlight/detail?id=2511426395","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2511426395?lang=en_us&edition=fundamental","pubTime":"2025-02-13 20:28","pubTimestamp":1739449691,"startTime":"0","endTime":"0","summary":"Given the large stake in the stock by institutions, eXoZymes' stock price might be vulnerable to their trading decisions. A total of 3 investors have a majority stake in the company with 58% ownership. To get a sense of who is truly in control of Invizyne Technologies, Inc. , it is important to understand the ownership structure of the business. We can see that institutions own the lion's share in the company with 42% ownership. In other words, the group stands to gain the most  from their investment into the company.Because institutional owners have a huge pool of resources and liquidity, their investing decisions tend to carry a great deal of weight, especially with individual investors. As a result, a sizeable amount of institutional money invested in a firm is generally viewed as a positive attribute.While studying institutional ownership for a company can add value to your research, it is also a good practice to research analyst recommendations to get a deeper understand of a stoc","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/institutional-investors-own-significant-stake-122811776.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["NVIW.SI","BK4585","NQmain","USAW.SI","IZTC","SQQQ","EXOZ","QID","IE00BGHQF748.EUR","TSYW.SI","LU2210150020.SGD","QLD","USJW.SI","PSQ","BK4112","BK4139","IE00BKPKM429.USD","BK4588","LU2095319765.USD",".IXIC","LU2210149790.SGD","IE00B3QW5Z07.USD","IE00B64PRP62.GBP","NDAQ","TQQQ","MNQmain"],"gpt_icon":1},{"id":"2510377867","title":"Rebranding Invizyne to eXoZymes Signifies a Sustainable Paradigm Shift in Chemical Production Leveraging AI-Engineered Enzymes","url":"https://stock-news.laohu8.com/highlight/detail?id=2510377867","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2510377867?lang=en_us&edition=fundamental","pubTime":"2025-02-12 21:50","pubTimestamp":1739368200,"startTime":"0","endTime":"0","summary":"Introducing but not trademarking “exozymes” as a new scientific nomenclature. “In response to feedback from our stakeholders and us having to continually explain which kind of ‘cell-free’ technology our platform falls under, we’re rebranding to both bring clarity around our core technology as well as set us apart from existing technologies. In fact, we believe that our technology is so fundamental and has so much potential that trying to label it with existing nomenclature falls short, which is why we’re introducing ‘exozymes’ as scientific concept,” states CEO of eXoZymes, Michael Heltzen. “We view exozymes as the logical successor to synthetic biology , as they essentially represent the missing last step for most SynBio projects: Scaling on an industrial level, which is fundamental for economic success but mostly has eluded the SynBio space this far.”Exozymes are advanced enzymes engineered using AI to thrive in a bioreactor outside of living cells. Exozymes can replace t","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/rebranding-invizyne-exozymes-signifies-sustainable-135000084.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["MDBH","BK4139","EXOZ","IZTC"],"gpt_icon":0}],"pageSize":20,"totalPage":1,"pageCount":1,"totalSize":17,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/EXOZ\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-03-31","symbol":"EXOZ","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1743393600000,"reportTimeType":"post","actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"EXOZ\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"EXOZ\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/EXOZ\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"EXOZ","date":"2025-05-06","current":-15.489771,"percent":0.892857,"low":-36.114743,"twenty":-31.729648,"median":-23.450408,"eighty":-15.738179,"high":-14.204905,"avg":-23.448861,"sd":7.258718,"marketCap":90790738},"quantilePoints":[{"date":"2025-02-14","current":-35.85439,"twenty":-35.270454,"median":-34.394551,"eighty":-33.518648,"marketCap":183715206},{"date":"2025-02-21","current":-32.339618,"twenty":-35.85439,"median":-34.989644,"eighty":-32.934712,"marketCap":165705779},{"date":"2025-02-28","current":-32.451198,"twenty":-35.370876,"median":-32.934712,"eighty":-32.451198,"marketCap":166277507},{"date":"2025-03-07","current":-26.835002,"twenty":-34.608413,"median":-32.525585,"eighty":-31.446978,"marketCap":137500540},{"date":"2025-03-14","current":-26.927986,"twenty":-33.845949,"median":-32.190845,"eighty":-26.927986,"marketCap":137976980},{"date":"2025-03-21","current":-28.062383,"twenty":-32.934712,"median":-31.43768,"eighty":-26.927986,"marketCap":143789546},{"date":"2025-03-28","current":-18.838432,"twenty":-32.934712,"median":-29.066604,"eighty":-26.834816,"marketCap":96526713},{"date":"2025-04-04","current":-16.972352,"twenty":-32.599972,"median":-28.118173,"eighty":-23.450408,"marketCap":99480640},{"date":"2025-04-11","current":-16.80319,"twenty":-32.451198,"median":-26.927986,"eighty":-18.578079,"marketCap":98489123},{"date":"2025-04-17","current":-15.875231,"twenty":-32.361934,"median":-26.927986,"eighty":-16.797479,"marketCap":93050047},{"date":"2025-04-25","current":-17.202926,"twenty":-32.2206,"median":-26.621047,"eighty":-16.710135,"marketCap":100832110},{"date":"2025-05-02","current":-15.703916,"twenty":-31.878421,"median":-24.380241,"eighty":-15.978021,"marketCap":92045910},{"date":"2025-05-06","current":-15.489771,"twenty":-31.729648,"median":-23.450408,"eighty":-15.738179,"marketCap":90790738}],"updateTime":1746620490659}}}